Large US study suggests survival benefit for severely ill COVID-19 patients treated with ECMO

(Wolters Kluwer Health) For critically ill COVID-19 patients treated with extracorporeal membrane oxygenation (ECMO), the risk of death remains high - but is much lower than suggested by initial studies, according to a report published today by Annals of Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer.